This conversation explores a nationwide Swedish study comparing Absorb bioresorbable scaffolds to drug-eluting stents in over 1,900 patients. While early complications were higher with scaffolds, long-term results suggest potential benefits including lower heart attack rates after three years.

SCAI Experts, Drs. Dean Kereiakes, Saman Saidi-Seresht, Patrick Serruys, and Gregg Stone discuss the highlights from this original research article.

Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103724